Timothy P Stevens

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. pmc Respiratory Outcomes of the Surfactant Positive Pressure and Oximetry Randomized Trial (SUPPORT)
    Timothy P Stevens
    Department of Pediatrics, University of Rochester Medical Center and Golisano Children s Hospital, Rochester, NY Electronic address
    J Pediatr 165:240-249.e4. 2014
  2. doi Evidence-based approach to preventing central line-associated bloodstream infection in the NICU
    Timothy P Stevens
    Division of Neonatology, Department of Pediatrics, University of Rochester School of Medicine, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Acta Paediatr Suppl 101:11-6. 2012
  3. ncbi Effect of cumulative oxygen exposure on respiratory symptoms during infancy among VLBW infants without bronchopulmonary dysplasia
    Timothy P Stevens
    Division of Neonatology, Department of Pediatrics, University of Rochester, Rochester, New York, USA
    Pediatr Pulmonol 45:371-9. 2010
  4. doi Timing of delivery and survival rates for infants with prenatal diagnoses of congenital diaphragmatic hernia
    Timothy P Stevens
    Department of Pediatrics, Division of Neonatology, University of Rochester, Rochester, New York, USA
    Pediatrics 123:494-502. 2009
  5. ncbi Survival in early- and late-term infants with congenital diaphragmatic hernia treated with extracorporeal membrane oxygenation
    Timothy P Stevens
    Division of Neonatology, Department of Pediatrics, Strong Children s Research Center, Golisano Children s Hospital at Strong, Rochester, New York 14642, USA
    Pediatrics 110:590-6. 2002
  6. ncbi Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease
    Nahed O Elhassan
    Division of Neonatology, Department of Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, USA
    Arch Pediatr Adolesc Med 160:1070-6. 2006
  7. ncbi Controversies in palivizumab use
    Timothy P Stevens
    Golisano Children s Hospital at Strong, University of Rochester Medical Center, Rochester, NY, USA
    Pediatr Infect Dis J 23:1051-2. 2004
  8. ncbi Longitudinal, 15-year follow-up of children born at less than 29 weeks' gestation after introduction of surfactant therapy into a region: neurologic, cognitive, and educational outcomes
    CARL T D'ANGIO
    Department of Pediatrics, Strong Children s Research Center, Golisano Children s Hospital at Strong, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    Pediatrics 110:1094-102. 2002
  9. pmc Adherence to guidelines for respiratory syncytial virus immunoprophylaxis among infants with prematurity or chronic lung disease in three United States counties
    Kecia N Carroll
    Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    Pediatr Infect Dis J 31:e229-31. 2012
  10. doi An evidence-based catheter bundle alters central venous catheter strategy in newborn infants
    Meggan Butler-O'Hara
    School of Nursing, University of Rochester, Rochester, NY, USA
    J Pediatr 160:972-7.e2. 2012

Research Grants

Detail Information

Publications18

  1. pmc Respiratory Outcomes of the Surfactant Positive Pressure and Oximetry Randomized Trial (SUPPORT)
    Timothy P Stevens
    Department of Pediatrics, University of Rochester Medical Center and Golisano Children s Hospital, Rochester, NY Electronic address
    J Pediatr 165:240-249.e4. 2014
    ....
  2. doi Evidence-based approach to preventing central line-associated bloodstream infection in the NICU
    Timothy P Stevens
    Division of Neonatology, Department of Pediatrics, University of Rochester School of Medicine, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Acta Paediatr Suppl 101:11-6. 2012
    ..To review care practices and methods of implementation that reduce the risk of central line-associated bloodstream infection (CLABSI)...
  3. ncbi Effect of cumulative oxygen exposure on respiratory symptoms during infancy among VLBW infants without bronchopulmonary dysplasia
    Timothy P Stevens
    Division of Neonatology, Department of Pediatrics, University of Rochester, Rochester, New York, USA
    Pediatr Pulmonol 45:371-9. 2010
    ..A possible explanation for these inconsistent findings is that the cumulative dosage of neonatal supplemental oxygen to which infants are exposure is difficult to accurately quantify...
  4. doi Timing of delivery and survival rates for infants with prenatal diagnoses of congenital diaphragmatic hernia
    Timothy P Stevens
    Department of Pediatrics, Division of Neonatology, University of Rochester, Rochester, New York, USA
    Pediatrics 123:494-502. 2009
    ....
  5. ncbi Survival in early- and late-term infants with congenital diaphragmatic hernia treated with extracorporeal membrane oxygenation
    Timothy P Stevens
    Division of Neonatology, Department of Pediatrics, Strong Children s Research Center, Golisano Children s Hospital at Strong, Rochester, New York 14642, USA
    Pediatrics 110:590-6. 2002
    ..Changes in survival rates of term infants and the factors associated with these changes were assessed over the 25 years that ECMO has been available...
  6. ncbi Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease
    Nahed O Elhassan
    Division of Neonatology, Department of Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, USA
    Arch Pediatr Adolesc Med 160:1070-6. 2006
    ....
  7. ncbi Controversies in palivizumab use
    Timothy P Stevens
    Golisano Children s Hospital at Strong, University of Rochester Medical Center, Rochester, NY, USA
    Pediatr Infect Dis J 23:1051-2. 2004
  8. ncbi Longitudinal, 15-year follow-up of children born at less than 29 weeks' gestation after introduction of surfactant therapy into a region: neurologic, cognitive, and educational outcomes
    CARL T D'ANGIO
    Department of Pediatrics, Strong Children s Research Center, Golisano Children s Hospital at Strong, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    Pediatrics 110:1094-102. 2002
    ..To measure the primary and secondary school-age neurologic, cognitive, and educational outcomes in a cohort of extremely premature infants born after the introduction of exogenous surfactant therapy in a circumscribed region...
  9. pmc Adherence to guidelines for respiratory syncytial virus immunoprophylaxis among infants with prematurity or chronic lung disease in three United States counties
    Kecia N Carroll
    Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    Pediatr Infect Dis J 31:e229-31. 2012
    ..Immunoprophylaxis among infants who met national criteria for prophylaxis increased from 33% to 83% over the 6-year period; 17% (11/65) of infants who received immunoprophylaxis did not meet eligibility criteria...
  10. doi An evidence-based catheter bundle alters central venous catheter strategy in newborn infants
    Meggan Butler-O'Hara
    School of Nursing, University of Rochester, Rochester, NY, USA
    J Pediatr 160:972-7.e2. 2012
    ....
  11. ncbi Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial
    Ann Reininger
    Strong Children s Research Center, University of Rochester, Rochester, NY 14642, USA
    J Perinatol 25:703-8. 2005
    ....
  12. ncbi Surfactant replacement therapy
    Timothy P Stevens
    Golisano Children s Hospital at Strong, University of Rochester, Rochester, NY, USA
    Chest 131:1577-82. 2007
    ..A specific CPT code for surfactant administration is scheduled to be introduced in 2007. This article reviews clinical issues in SRT and the practice management considerations necessary to provide this care...
  13. ncbi Vancomycin usage in central venous catheters in a neonatal intensive care unit
    Nahed O Elhassan
    Division of Neonatology, Golisano Children s Hospital at Strong, Rochester, NY, USA
    Pediatr Infect Dis J 23:201-6. 2004
    ..The use of vancomycin was reserved for documented infections with vancomycin-susceptible organisms...
  14. doi Statewide NICU central-line-associated bloodstream infection rates decline after bundles and checklists
    Joseph Schulman
    Weill Medical College, Cornell University, Pediatrics Newborn Medicine, 525 East 68th St, Box 106, New York, New York 10021, USA
    Pediatrics 127:436-44. 2011
    ..We sought to confirm whether adopting standardized bundles and using central-line maintenance checklists reduced central-line-associated bloodstream infections (CLABSI)...
  15. ncbi Infant race affects application of clinical guidelines when screening for drugs of abuse in newborns
    Marc A Ellsworth
    Strong Children s Research Center, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
    Pediatrics 125:e1379-85. 2010
    ..Established drug-screening criteria may be applied in a manner that considers nonproven risk factors such as race in addition to evidence-based factors...
  16. pmc Risk factors for umbilical venous catheter-associated thrombosis in very low birth weight infants
    Shalu Narang
    University of Rochester, Rochester, New York 14642, USA
    Pediatr Blood Cancer 52:75-9. 2009
    ..The objective of this study was to investigate the risk factors associated with catheter related thrombosis in very low birth weight (VLBW) infants...
  17. ncbi Development of a statewide collaborative to decrease NICU central line-associated bloodstream infections
    J Schulman
    Department of Pediatrics Newborn Medicine, Weill Cornell Medical College, Weill Cornell Medical Center, New York, NY, USA
    J Perinatol 29:591-9. 2009
    ....
  18. ncbi Guidelines for palivizumab prophylaxis: are they based on infant's risk of hospitalization for respiratory syncytial viral disease?
    Nahed O Elhassan
    Division of Neonatology, Department of Pediatrics, Strong Children s Research Center, University of Rochester, Rochester, NY, USA
    Pediatr Infect Dis J 22:939-43. 2003
    ..Multiple studies have been published that assess the risk of hospitalization for RSV disease by gestational age (GA) at birth and severity of lung disease...

Research Grants2

  1. Oxygen, Oxidant Stress and Wheezing in Premature Infants
    Timothy Stevens; Fiscal Year: 2007
    ..By evaluating the effect of oxygen exposure on oxidant stress and airway dysfunction this award will identify new therapeutic approaches to improve respiratory health of preterm infants in early childhood. ..